These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5777190)

  • 21. [Experiences with the use of vitamin B15 in the treatment of certain diseases of the liver].
    Anisimov VE
    Sov Med; 1966 Jun; 29(6):107-10. PubMed ID: 5988439
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of acute and chronic liver diseases with combinations of vitamin B12 and anabolic hormones].
    Boeder KJ; Schmidt H; Khamsi A
    Med Welt; 1966 Apr; 14():730-4. PubMed ID: 5957304
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results of therapy of active chronic hepatopathies with 6-mercaptopurine].
    Schneider G; Schimmelpfennig W; Theuer D; Wagner K; Zimmermann HB; Nack P
    Z Gesamte Inn Med; 1969 Apr; 24(8):Suppl:124-6. PubMed ID: 5802052
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mesenchyma-suppressing therapy of chronic aggressive hepatitis].
    Gros H; Zwirner K; Herzog W
    Med Klin; 1972 Oct; 67(40):1277-82. PubMed ID: 4638147
    [No Abstract]   [Full Text] [Related]  

  • 25. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
    Tamarkina AD; Neverov IV; Turitsyna IG; Dement'eva ES; Krylova NI
    Sov Med; 1985; (12):26-30. PubMed ID: 4095626
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic trials with essential phospholipids in various liver diseases].
    Alcalá-Santaella R; Fernández-Pacheco A; García García FJ; Alvarez Fernández E
    Rev Esp Enferm Apar Dig; 1972; 38(2):247-60. PubMed ID: 5073060
    [No Abstract]   [Full Text] [Related]  

  • 27. [Essentiale in chronic liver diseases].
    Maleev A; Krustev Z; Tsvetkova V
    Vutr Boles; 1983; 22(6):36-45. PubMed ID: 6673345
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinico-morphological dynamics of chronic diffuse liver diseases].
    Loginov AS; Blok IuE; Shepeleva SD; Tkachev VD
    Ter Arkh; 1981; 53(11):50-9. PubMed ID: 7339906
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical study on the effects of coenzyme A in liver diseases].
    Kanematsu Y; Okawa S; Himoto A; Inoue Y; Onishi K
    Naika Hokan; 1968 Mar; 15(3):67-75. PubMed ID: 5691520
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of Nucleotide precursors on experimental and clinical chronic hepatic disorders (a preliminary report).
    Katsuki S; Okumura M; Akitake T; Toyoshima Y; Nishi K; Furukawa K
    Kyushu J Med Sci; 1964 Dec; 15(5):171-81. PubMed ID: 5827933
    [No Abstract]   [Full Text] [Related]  

  • 31. [Possibility of preventing the chronicity of hepatitis using agents inhibiting fibrous tissue formation--a pathological viewpoint].
    Miyaji T
    Nihon Rinsho; 1970 Feb; 28(2):291-3. PubMed ID: 5462723
    [No Abstract]   [Full Text] [Related]  

  • 32. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
    Okolicsànyi L; Orlando R; Lirussi F; Naccarato R; Dal Brun G
    Clin Ter; 1980 May; 93(4):431-8. PubMed ID: 6998643
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of chronic hepatitis and liver cirrhosis].
    Kommerell B
    Med Welt; 1974 Nov; 25(46):1904-10. PubMed ID: 4456135
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evolution of chronic diffuse liver diseases treated by essential choline phospholipid therapy. Clinical and analytical control through exploration with radioactive isotopes].
    Galán Navarro JL
    Rev Esp Enferm Apar Dig; 1967 Apr; 26(4):460-90. PubMed ID: 5603013
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of bovine gallstone (Goou) and bear gall powder (Yutan) on chronic liver diseases: a preliminary report.
    Matsumoto N; Nakashima T; Kashima K
    Tokai J Exp Clin Med; 1995 May; 20(1):9-16. PubMed ID: 8869449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On the therapy of chronic inflammatory liver diseases without or with vitamin B 12-folic acid].
    Burgmann W
    Munch Med Wochenschr; 1966 Sep; 108(37):1805-8. PubMed ID: 6014771
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of the in vitro effect of hydrocortisone and D-penicillamine on the liver of patients with chronic hepatitis and liver cirrhosis].
    Gichev IuP; Bakulina LF
    Ter Arkh; 1980; 52(7):113-7. PubMed ID: 7404399
    [No Abstract]   [Full Text] [Related]  

  • 39. [Our experience with long-term therapy of chronic liver diseases using Superanabolon Spofa].
    Svacinka P; Horký J; Blahníková L
    Vnitr Lek; 1970 Dec; 16(12):1181-7. PubMed ID: 5491517
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic results in active chronic hepatopathies using 6-mercaptopurine].
    Schneider G; Schimmelpfennig W; Theuer D; Wagner K; Zimmermann HB; Nack P
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:124-6. PubMed ID: 5402568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.